Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
Am J Med
    September 2021
  1. SAUNDERS S, Braghirol K, Carbo A
    Posterior Circulation Strokes Leave Many Bedside HINTS.
    Am J Med. 2021;134:e480-e481.
    >> Share

    August 2021
  2. HONAN KA, Jogimahanti A, Khair T
    An updated review of the efficacy and safety of direct oral anticoagulants in treatment of left ventricular thrombus.
    Am J Med. 2021 Aug 29. pii: S0002-9343(21)00508.
    >> Share

    Ischemic Stroke.
    Am J Med. 2021 Aug 26. pii: S0002-9343(21)00512.
    >> Share

    May 2021
  4. DUBIN I, Schattner A, Glick Y
    Subclavian Steal Syndrome, Cerebellar Infarctions, and Alcohol.
    Am J Med. 2021;134:e317-e318.
    >> Share

    April 2021
  5. OMELCHENKO A, Hornik-Lurie T, Gabay H, Minha S, et al
    LDL Cholesterol and Ischemic Stroke in Patients with Nonvalvular Atrial Fibrillation.
    Am J Med. 2021;134:507-513.
    >> Share

    March 2021
  6. ESCHLER CM, Antelo A, Funk GC, Exadaktylos AK, et al
    High Fluctuation Between Anticoagulants, Frequent Off-Label Dosing, and No Difference Concerning Outcomes: Results of a Real-Life Cohort Study.
    Am J Med. 2021;134:e165-e170.
    >> Share

    February 2021
  7. GIBBS H, Freedman B, Rosenqvist M, Virdone S, et al
    Clinical outcomes in asymptomatic and symptomatic atrial fibrillation presentations in GARFIELD-AF: Implications for atrial fibrillation screening.
    Am J Med. 2021 Feb 16. pii: S0002-9343(21)00096.
    >> Share

    January 2021
  8. OVERVAD TF, Skjoth F, Albertsen IE, Larsen TB, et al
    Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation?
    Am J Med. 2021;134:67-75.
    >> Share

    December 2020
  9. MALJAARS J, Ortega-Gutierrez S, Cho T, Shaban A, et al
    Q Fever, CNS Vasculitis, and Stroke: A Case Report.
    Am J Med. 2020;133:e729-e730.
    >> Share

    November 2020
  10. SHAH S, Patel S, Paulraj S, Chaudhuri D, et al
    Association of Marijuana Use and Cardiovascular Disease: A Behavioral Risk Factor Surveillance System Data Analysis of 133,706 US Adults.
    Am J Med. 2020 Nov 9. pii: S0002-9343(20)30959.
    >> Share

  11. KUMAR K, Kheiri B, Simpson TF, Osman M, et al
    Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: A Meta-Analysis of Randomized Clinical Trials.
    Am J Med. 2020;133:e625-e630.
    >> Share

  12. DE CATERINA R, Procopio A, Lopez Sendon JL, Raev D, et al
    Comparison of Dabigatran Plus a P2Y12 Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI.
    Am J Med. 2020;133:1302-1312.
    >> Share

  13. GUE YX, Sayers M, Whitby BT, Kanji R, et al
    Usefulness of the NULL-PLEASE Score to Predict Survival in Out-of-Hospital Cardiac Arrest.
    Am J Med. 2020;133:1328-1335.
    >> Share

    October 2020
  14. ZULTY M, Saleh N, Hernandez J, Kalaria A, et al
    Catheter-Directed Therapy: Outcomes vs Standard of Care and Evaluation of Current Practice.
    Am J Med. 2020 Oct 31. pii: S0002-9343(20)30932.
    >> Share

  15. GUO Y, Lane DA, Chen Y, Lip GYH, et al
    Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial.
    Am J Med. 2020;133:1195-1202.
    >> Share

    September 2020
  16. VITALIS A, Shantsila A, Proietti M, Vohra RK, et al
    Peripheral arterial disease in patients with atrial fibrillation: The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study.
    Am J Med. 2020 Sep 18. pii: S0002-9343(20)30799.
    >> Share

  17. SCHATTNER A, Glick Y, Dubin I
    Coma During a Febrile Illness - Respiratory Syncytial Virus-Triggered Ischemic Stroke.
    Am J Med. 2020;133:e521-e523.
    >> Share

    August 2020
  18. SCHATTNER A, Glick Y, Dubin I
    An Underappreciated Embolic Source: Aortic Arch Floating Thrombus.
    Am J Med. 2020;133:e430-e431.
    >> Share

  19. NADKARNI N, Lee YJ, Hoefen R, Alweis R, et al
    Cholangiocarcinoma Manifesting as Non-Bacterial Thrombotic Endocarditis in a Young Patient.
    Am J Med. 2020;133:e396-e398.
    >> Share

    July 2020
  20. GITIN A, Pfeffer MA, DeMets DL, Hennekens CH, et al
    Aspirin in Primary Prevention: Needs Individual Clinical Judgments.
    Am J Med. 2020;133:774-776.
    >> Share

    June 2020
  21. DESANTIS DJ, Patel PB, Gerova L, Grady DW, et al
    The Anti-Platelet Anomaly: Aspirin/Dipyridamole-Induced Acute Pancreatitis.
    Am J Med. 2020;133:e220-e222.
    >> Share

    May 2020
  22. LIU J, Elbadawi A, Elgendy IY, Megaly M, et al
    Age-Stratified Sex Disparities in Care and Outcomes in Patients with ST-elevation Myocardial Infarction.
    Am J Med. 2020 May 14. pii: S0002-9343(20)30375.
    >> Share

  23. PAULRAJ S, Kumar PA, Carvounis CP
    Spontaneous Aortic Arch Thrombus in a Young Female Successfully Managed with Long Term Anticoagulation Alone.
    Am J Med. 2020 May 13. pii: S0002-9343(20)30371.
    >> Share

  24. ESCHLER CM, Woitok BK, Funk GC, Walter P, et al
    Oral Anticoagulation in Patients in the Emergency Department: High Rates of Off-Label Doses, No Difference in Bleeding Rates.
    Am J Med. 2020;133:599-604.
    >> Share

    April 2020
  25. CLAXTON JS, Chamberlain AM, Lutsey PL, Chen LY, et al
    Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 years and older with Atrial Fibrillation.
    Am J Med. 2020 Apr 19. pii: S0002-9343(20)30344.
    >> Share

  26. WANG SJ
    An Unusual Cause of Stroke: Neurosarcoidosis.
    Am J Med. 2020;133:e117-e119.
    >> Share

    March 2020
  27. FANGEL MV, Nielsen PB, Kristensen JK, Larsen TB, et al
    Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes without Cardiovascular Disease: A Danish Cohort Study.
    Am J Med. 2020 Mar 20. pii: S0002-9343(19)31094.
    >> Share

  28. KOSHY AN, Hamilton G, Theuerle J, Teh AW, et al
    Postoperative Atrial Fibrillation Following Noncardiac Surgery Increases Risk of Stroke.
    Am J Med. 2020;133:311-322.
    >> Share

  29. HANSEN TG, Pottegard A, Brandes A, Ekelund U, et al
    New-Onset Atrial Fibrillation Among Patients With Infection in the Emergency Department: A Multicenter Cohort Study of 1-Year Stroke Risk.
    Am J Med. 2020;133:352-359.
    >> Share

    January 2020
  30. JANG SK, Castillo Almeida NE, Ambroz R, Wilson W, et al
    Varicella-Zoster Virus Vasculopathy Leading to Multi-Focal Stroke in an Immunocompromised Patient.
    Am J Med. 2020;133:e3-e4.
    >> Share

    Central Poststroke Pain with Wallenberg Syndrome.
    Am J Med. 2020;133:e11-e12.
    >> Share

  32. SALVATORE T, Morganti R, Marchioli R, De Caterina R, et al
    Cholesterol Lowering and Stroke: No Longer Room for Pleiotropic Effects of Statins - Confirmation from PCSK9 Inhibitor Studies.
    Am J Med. 2020;133:95-99.
    >> Share

    November 2019
  33. CHANG SH, Wu CV, Yeh YH, Kuo CF, et al
    Efficacy and Safety of Oral Anticoagulants in Patients With Atrial Fibrillation and Stages 4 or 5 Chronic Kidney Disease.
    Am J Med. 2019;132:1335-1343.
    >> Share

    October 2019
  34. GRAHAM DJ, Baro E, Wernecke M, Kelman JA, et al
    The Reply.
    Am J Med. 2019;132:e754-e755.
    >> Share

  35. WANG Y, Chen T, Dodd J, Li W, et al
    Appropriate Interpretation of the Observed NOACs Treatment Effect Size in Real-world Study.
    Am J Med. 2019;132:e752-e753.
    >> Share

    September 2019
  36. DAVIS KA, Huang G, Petty SA, Tan WA, et al
    The effect of pre-existing anticoagulation on cerebrovascular events in left-sided infective endocarditis.
    Am J Med. 2019 Sep 5. pii: S0002-9343(19)30724.
    >> Share

  37. COLEMAN CI, Kreutz R, Sood NA, Bunz TJ, et al
    Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.
    Am J Med. 2019;132:1078-1083.
    >> Share

    August 2019
  38. FRANCHI C, Antoniazzi S, Ardoino I, Proietti M, et al
    Simulation-Based Education for Physicians to Increase Oral Anticoagulants in Hospitalized Elderly Patients with Atrial Fibrillation.
    Am J Med. 2019;132:e634-e647.
    >> Share

    July 2019
  39. VERHEUGT FW, Ambrosio G, Atar D, Bassand JP, et al
    Outcomes in newly diagnosed atrial fibrillation and history of acute coronary syndromes: insights from GARFIELD-AF.
    Am J Med. 2019 Jul 12. pii: S0002-9343(19)30543.
    >> Share

    June 2019
  40. ABDEL-WAHED L, Shaban A, Hayakawa M, Limaye K, et al
    Retrieved Arterial Clot Helps Guide Antibiotic Therapy in Infective Endocarditis.
    Am J Med. 2019 Jun 20. pii: S0002-9343(19)30469.
    >> Share

  41. PATTI G, Pecen L, Lucerna M, Huber K, et al
    Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation.
    Am J Med. 2019;132:749-757.
    >> Share

    May 2019
  42. GRAHAM DJ, Baro E, Zhang R, Liao J, et al
    Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation.
    Am J Med. 2019;132:596-604.
    >> Share

    March 2019
  43. XIONG Y, Manwani B, Fisher M
    Management of Acute Ischemic Stroke.
    Am J Med. 2019;132:286-291.
    >> Share

    January 2019
  44. PASTORI D, Farcomeni A, Pignatelli P, Violi F, et al
    ABC (Atrial fibrillation Better Care) pathway and healthcare costs in atrial fibrillation. The ATHERO-AF study.
    Am J Med. 2019 Jan 16. pii: S0002-9343(19)30063.
    >> Share

  45. PRISTIPINO C, Roncella A, Pasceri V, Speciale G, et al
    Short-TErm Psychotherapy IN Acute Myocardial Infarction (STEP-IN-AMI) TRIAL: Final results.
    Am J Med. 2019 Jan 16. pii: S0002-9343(19)30053.
    >> Share

  46. RODWIN BA, Salami JA, Spatz ES, Valero-Elizondo J, et al
    Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost Implications.
    Am J Med. 2019;132:61-70.
    >> Share

    November 2018
  47. MORICI N, Savonitto S, Ferri LA, Grosseto D, et al
    Am J Med. 2018 Nov 14. pii: S0002-9343(18)31053.
    >> Share

    October 2018
  48. HENNEMEYER C, Khan A, McGregor H, Moffett C, et al
    Outcomes of Catheter Directed Therapy Plus Anticoagulation Versus Anticoagulation Alone for Submassive and Massive Pulmonary Embolism with Subgroup Analysis.
    Am J Med. 2018 Oct 24. pii: S0002-9343(18)31032.
    >> Share

    July 2018
  49. SHATHER Z, Laverty AA, Bottle A, Watt H, et al
    Sustained socio-economic inequalities in hospital admissions for cardiovascular events among people with diabetes in England.
    Am J Med. 2018 Jul 25. pii: S0002-9343(18)30647.
    >> Share

    May 2018
  50. ADAMS K, Kearney M, Lee K, Rhoney D, et al
    Strength in Numbers: A Team-Based Approach to Managing Patients with Hyponatremia.
    Am J Med. 2018 May 24. pii: S0002-9343(18)30438.
    >> Share

  51. HARIRI E, Tisminetzky M, Lassard D, Yarzebski J, et al
    Twenty-five year (1986-2011) trends in the incidence and death rates of stroke complicating acute myocardial infarction.
    Am J Med. 2018 May 3. pii: S0002-9343(18)30395.
    >> Share

    January 2018
  52. LEVIN SN, Lyons JL
    Infections of the Nervous System.
    Am J Med. 2018;131:25-32.
    >> Share

    December 2017
  53. MELLONI C, Dunning A, Granger CB, Thomas L, et al
    Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial.
    Am J Med. 2017;130:1440-1448.
    >> Share

    November 2017
  54. NAZZAL S, Hijazi B, Khalila L, Blum A, et al
    Diagonal Earlobe Crease (Frank's Sign): A Predictor of Cerebral Vascular Events.
    Am J Med. 2017;130:1324.
    >> Share

    September 2017
  55. FANIKOS J, Burnett AE, Mahan CE, Dobesh PP, et al
    Renal Function Considerations for Stroke Prevention in Atrial Fibrillation.
    Am J Med. 2017;130:1015-1023.
    >> Share

    July 2017
  56. POTPARA TS, Lip GYH, Blomstrom-Lundqvist C, Chiang CE, et al
    Viewpoint: Stroke Prevention in Recent Guidelines for the Management of Patients with Atrial Fibrillation: An Appraisal.
    Am J Med. 2017;130:773-779.
    >> Share

    June 2017
  57. BANGALORE S, Toklu B, Gianos E, Schwartzbard A, et al
    Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials.
    Am J Med. 2017;130:707-719.
    >> Share

    April 2017
  58. RENDA G, Ricci F, De Caterina R
    Non-Vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation: An Updated Meta-analysis.
    Am J Med. 2017;130:457-461.
    >> Share

    March 2017
  59. DALEN JE, Alpert JS
    Silent Atrial Fibrillation and Cryptogenic Strokes.
    Am J Med. 2017;130:264-267.
    >> Share

  60. BARBARYAN A, Bailuc S, Raqeem MW, Kak M, et al
    Wake-Up Call: Pulmonary Arteriovenous Malformation.
    Am J Med. 2017;130:290-292.
    >> Share

    February 2017
  61. MAZUREK M, Huisman MV, Lip GY
    Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice.
    Am J Med. 2017;130:135-145.
    >> Share

    December 2016
  62. BIENER M, Giannitsis E, Kuhner M, Zelniker T, et al
    Prognostic value of high-sensitivity cardiac troponin T compared to riskscores in stable cardiovascular disease.
    Am J Med. 2016 Dec 20. pii: S0002-9343(16)31242.
    >> Share

  63. FAUCHIER L, Villejoubert O, Clementy N, Bernard A, et al
    Causes of Death and Influencing Factors in Patients with Atrial Fibrillation.
    Am J Med. 2016;129:1278-1287.
    >> Share

    November 2016
  64. DE SOUZA BRITO F, Mehta RH, Lopes RD, Harskamp RE, et al
    Non-Steroidal Anti-Inflammatory Drugs and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Surgery.
    Am J Med. 2016 Nov 22. pii: S0002-9343(16)31197.
    >> Share

  65. DALEN JE, Alpert JS
    Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
    Am J Med. 2016;129:1159-1162.
    >> Share

  66. BARRA ME, Fanikos J, Connors JM, Sylvester KW, et al
    Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
    Am J Med. 2016;129:1198-1204.
    >> Share

  67. EIKELBOOM J, Merli G
    Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience.
    Am J Med. 2016;129.
    >> Share

  68. MILLING TJ JR, Kaatz S
    Preclinical and Clinical Data for Factor Xa and "Universal" Reversal Agents.
    Am J Med. 2016;129.
    >> Share

  69. VILLINES TC, Peacock WF
    Safety of Direct Oral Anticoagulants: Insights from Postmarketing Studies.
    Am J Med. 2016;129.
    >> Share

  70. MILLING TJ JR, Spyropoulos AC
    Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed.
    Am J Med. 2016;129.
    >> Share

    October 2016
  71. ALEXANDER GC, Iyer G, Lucas E, Lin D, et al
    Cardiovascular risks of exogenous testosterone use among men: A systematic review and meta-analysis.
    Am J Med. 2016 Oct 14. pii: S0002-9343(16)31024.
    >> Share

  72. RENDA G, Zimarino M, Ricci F, Piccini JP, et al
    Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation.
    Am J Med. 2016;129:1117-1123.
    >> Share

  73. PEREG D, Rozenbaum Z, Vorobeichik D, Shlomo N, et al
    Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Stroke.
    Am J Med. 2016;129:1074-81.
    >> Share

  74. PROIETTI M, Lip GY
    Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials.
    Am J Med. 2016;129:1110-6.
    >> Share

    May 2016
  75. RUFF CT, Ansell JE, Becker RC, Benjamin EJ, et al
    North American Thrombosis Forum, AF Action Initiative Consensus Document.
    Am J Med. 2016;129.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016